This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Adizem-SR 90 mg Prolonged Release Capsules PA1688/001/001 Mundipharma Pharmaceuticals Limited | Diltiazem |
| Areloger 7.5mg Tablets PA0577/057/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Meloxicam |
| Areloger 15mg Tablets
PA0577/057/002
McDermott Laboratories Ltd., T/A Gerard Laboratories | Meloxicam |
| Ativan 1mg Tablets PA0822/090/001 Pfizer Healthcare Ireland | Lorazepam |
| Atorvastatin Mylan 80mg Film Coated Tablets PA0577/118/004 McDermott Laboratories Ltd., T/A Gerard Laboratories | Atorvastatin |
| Oramox 125mg/5ml Powder for Oral Suspension PA0298/019/001 Athlone Laboratories Ltd | Amoxicillin |
| Parnate 10mg Tablet PA1142/035/001 Amdipharm Limited | Tranylcypromine |
| Prednisolone 1mg Tablets PA0126/027/002 Clonmel Healthcare Ltd | Prednisolone |
| Tevanate Once Weekly 70mg Tablets
PA0749/016/001
Teva Pharma B.V. | Alendronic acid |
| Zovirax IV for Infusion 250 mg, Powder for Solution for Infusion PA1077/084/003 GlaxoSmithKline (Ireland) Limited | Aciclovir |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Alprazolam 0.25 mg Tablets PA0711/140/001 Rowex Ltd | Alprazolam |
| Aspirin 300mg Effervescent Tablets PA1410/037/001 Bayer Limited | Aspirin |
| Canesten 500mg Pessary PA1410/039/009 Bayer Limited | Clotrimazole |
| Clarithromycin Teva 250mg Film Coated Tablets PA0749/148/001 Teva Pharma B.V. | Clarithromycin |
| Efient 10mg Tablets EU/1/08/503/009 Substipharm | Prasugrel |
| Ganfort Eye Drops EU/1/06/340/004 AbbVie Deutschland GmbH & Co. KG | Bimatoprost & timolol |
| Gerax 250mcg Tablets PA1445/024/001 Aurobindo Pharma (Malta) Limited | Alprazolam |
| Keflex 250mg Hard Capsules PA1226/002/001 Flynn Pharma Limited | Cephalexin |
| Keflex 500mg Hard Capsules PA1226/002/004 Flynn Pharma Limited | Cephalexin |
| Keflex 125mg/5ml Powder for Oral Suspension PA1226/002/002 Flynn Pharma Limited | Cephalexin |
| Mirtazapine 15mg Film-Coated Tablets PA2315/072/001 Accord Healthcare Ireland Ltd. | Mirtazapine |
| Neurostil 100mg Capsules PA0749/164/001 Teva Pharma B.V. | Gabapentin |
| Neurostil 400mg Capsules PA0749/164/001 Teva Pharma B.V. | Gabapentin |
| Roaccutane 20mg Soft Capsules PA2307/007/002 Roche Products (Ireland) Ltd | Isotretinoin |
| Stemetil 12.5mg/ml Solution for Injection PA0540/127/002 Sanofi-Aventis Ireland Limited T/A SANOFI | Prochlorperazine |
| Vidisic 0.2% Eye Gel PA23259/008/001 Bausch + Lomb Ireland Limited | Carbomer |
| Vidisic Preservative Free Single Dose Unit PA23259/008/002 Bausch + Lomb Ireland Limited | Carbomer |
| Vividrin Preservative Free SDU 2% w/v Eye Drops solution PA23259/005/002 Bausch + Lomb Ireland Limited | Sodium cromoglycate |
| Xanax 250mcg Tablets PA23055/010/002 Upjohn EESV | Alprazolam |
| Xylocaine 2% with Adrenaline PA1691/027/001 Aspen Pharma Trading Limited | Adrenaline & lidocaine |
| Zanidip 20mg Film-Coated Tablets PA0812/001/002 Recordati Industria Chimica e Farmaceutica SpA | Lercanidipine |
| Zindaclin 1% Gel PA23139/001/001 Canute Pharma (Ireland) Limited | Clindamycin |
| Zolepant 40mg Gastro-Resistant Tablets PA0281/140/002 Pinewood Laboratories Ltd | Pantoprazole |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.